Ophthotech reported $17.54M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Alimera Sciences ALIM:US USD 9.86M 46K
Bioline Rx BLRX:US USD 2.71M 502K
Cytrx CYTR:US USD 51.91K 1.93M
Insmed INSM:US USD 73.48M 2.1M
Nektar Therapeutics NKTR:US USD 21.94M 595K
Novartis NOVN:VX USD 3.7B 295M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Roche Holding ROG:VX 6.48B 834M